A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema
Clinical trial NCT02994771 · TERMINATED
Trial details
- NCT number
- NCT02994771
- Sponsor
- Herantis Pharma Plc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2019-02-03
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.